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ABSTRACT 
The linear nonthreshold (LNT) model plays a central role in low-dose radiation 
risk assessment for humans. With the LNT model, any radiation exposure is as- 
sumed to increase one's risk of cancer. Based on the LNT model, others have 
predicted tens of thousands of deaths related to environmental exposure to radio- 
active material from nuclear accidents (e.g., Chernobyl) and fallout from nuclear 
weapons testing. Here, we introduce a mechanism-based model for low-dose, radia- 
tion-i~~tlucetl, stochastic effects (genomic instability, apoptosis, mutations, neoplas- 
tic. trnllsforl~~ntio~~) that leads to a LNT relationship between the risk for neoplastic 
t l . ;~~~sf i )~ . l~~at ion  and d se only in special cases. It is shown that nonlinear dose- 
response relationships for risk of stochastic effects (problematic nonlethal muta- 
tions, neoplastic transformation) should be expected based on known biological 
mechanisms. Further, for low-dose, low-dose rate, low-LET radiation, large thresh- 
olds may exist for cancer induction. We summarize previously published data 
demonstrating large thresholds for cancer induction. We also provide evidence for 
lowdose-radiation-induced, protection (assumed via apoptosis) from neoplastic 
transformation. We speculate based on work of others (Chung 2002) that such 
protection may also be induced to operate on existing cancer cells and may be 
amplified by apoptosis-inducing agents such as dietary isothiocyanates. 
Key Words: radiation, risk, low dose, model. 
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INTRODUCTION 
The shape of the dose-response curve for stochastic effects (mutations, neoplastic 
transformation, cancer) after exposure to low doses of ionizing radiation has for 
years been the topic of enormous debate, yet this debate continues (Crawford- 
Brown and Hofrnann 1990, 1993; Chen and Wei 1991; Bond et al. 1995; Rossi and 
Zaider 1997; Becker 1998, 2002; Bogen 1998; Calabrese and Baldwin 1998, 1999; 
Calabrese et al. 1999; Kondo 1999; Pollycove and Feinendegen 1999; Brenner et al. 
2001; Feinendegen and Pollycove 2001; NCRP 2001; Schollnberger el al. 2001a, b, 
2002). The key discussion relates to whether the linear nonthreshold (LNT) model 
for low-dose extrapolation of cancer risk is valid. This model is widely used by 
regulatory agencies and in radiation and chemical protection. With the LNT hy- 
pothesis, risk progressively increases as dose increases. Any amount of carcinogen 
exposure increases one's risk of cancer. Thus, for radiation, any exposure is as- 
sumed to increase one's risk of cancer. Tens of thousands of cancer deaths in the 
U.S. have been calculated to arise from fallout from nuclear weapons testing (CDC/ 
NCI 2001). Similar numbers could possibly emerge if one chose to use the LNT 
model to calculate cancer deaths from inhaling smoke from forest fires that have 
occurred over the years (which contains naturally occurring and manmade radionu- 
clides) . 
Other possible dose-response CUNeS (linear-threshold, sigmoid, u-shaped, etc.) 
are considered to be more in line with known mechanisms of carcinogenesis 
(Feinendegen et al. 1999,2000; Pollycove and Feinendegen 1999; Feinendegen and 
Pollycove 2001; Schollnberger et al. 2002). The principal worker protection and 
public health implication is that if a threshold response were assumed, then expo- 
sures below the threshold value would be considered safe (Calabrese and Baldwin 
1999). 
It is highly unlikely that use of the LNT model will be abandoned by regulatory 
agencies and in radiation/chemical protection unless substailtial evidence of thresh- 
olds can be demonstrated from epidemiological studies and from mechanisms- 
based experimental and theoretical investigations. Now there is growing evidence 
from epidemiological, experimental, and mathematical modeling studies that does 
not support use of the LNT model for central estimation of cancer risks at low doses. 
Instead, the results support the existence of thresholds (quite large in some cases) 
for radiation-induced excess cancers, possibly in association with complex dose- 
response relationships (e.g. u-shaped). The u-shaped dose-response relationship is 
well known among researchers of hormesis (Calaberse and Baldwin 1998, 1999; 
Calabrese et al. 1999; Ducoff 2002). 
The focus of this paper is to use a mechanisms-based model (called NEOTRANS,) 
for radiation-induced neoplastic transformation (considered an early stage in can- 
cer development), to show how thresholds for specific radiation-induced excess 
stochastic effects (problematic nonlethal mutations and neoplastic transformation) 
could arise in some cases as a result of natural protection (resilience) from radia- 
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tion-induced damage. Results for radiation may also apply to genotoxic chemicals. 
The NEOTRANS, model was mainly developed over the last 4 years largely in the 
absence of supporting data initially for key modeling assumptions. However, over 
these years, supporting data have slowly emerged via publications and presentations 
by others in a variety of fields. Here, we introduce and explain the supporting data 
and present the NEOTRANS, model as though it were developed based on existing 
data to support key modeling assumptions. This form of presentation was selected 
to help the reader feel more familiar with these assumptions (as some relate to novel 
mechanisms) when presented. 
MOLECULAR MECHANISMS ASSOCIATED WITH CARCINOGENESIS 
Macromolecular Changes 
Ionizing radiation induces a range of DNA damage similar to that which arises 
endogenously from reactive oxygen species generated as byproducts of metabolism 
Ueggo 2002). Daniel Billen (1990), in discussing the concept of negligible dose in 
the context of naturally occurring DNA damage and repair, has reported that 
thousailds of spontaileous DNAdamaging events occur in each cell each day. 
Robert Stewart (1999) reported an estimate (best estimate) numerically equivalent 
to 10bpontaneous "Locally Multiple Damage Sites" (in particular double strand 
breaks) occurring in DNA, per million cells, per day. These lesions are quickly 
repaired, essentially error free in most cases. It is highly plausible that adding a few 
tens or hundreds more of such lesions through lowdose radiation (especially low- 
LET radiation) or lowdose chemical exposure is unlikely to overwhelm the cell's 
highly efficient damage repair machinery. Therefore, it is reasonable that error-free 
repair could operate after very low doses of low-LET radiation or genotoxic chemi- 
cal. 
Numerous repair processes are now known and include nucleotide excision 
repair, base excision repair, transcriptioncoupled repair, mismatch repair, and 
nonhomologous end joining (Friedberg et al. 1995; Scicchitano and Mellon 1997; 
Hanawalt 2001). The indicated repair processes operate at the individual cell level 
and provide for individual cell resilience to vulnerable states. A complex cell 
signaling network regulates the individual-resilience system. The failure of this 
system can lead to repair errors, which in turn can lead to problematic lethal and 
nonlethal mutations (forms of genomic instability). 
Operationally, two types of mutations (heightened vulnerability states) are used 
to classify genes: (1) those where a mutation causes a gain in function ( protooncogene 
to oncogene change); and (2) those where mutations cause function loss (tumor 
suppressor genes). In the development of leukemia and lymphoma, the first step is 
considered to be activation of a protooncogene into an oncogene, which arises via 
a translocation of a promoter beside the active site of a normally repressed growth- 
promoting gene site (Young 1994). 
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In the case of thyroid cancer, specific genes are rearranged that involve activation 
of the ret protooncogene (Jacob et al. 1996; Rabes and Klugbauer 1998; Smida el al. 
1999). Whereas oncogene activations are quite specific, for tumor suppressor gene 
mutations, random deletions of large amounts of DNA, large parts of a gene, an 
entire gene, or several genes could occur. For many solid tumors, the inactivation 
of a tumor suppressor gene is considered to be the first step in the cancer induction 
process and is commonly assumed to affect a tissue-specific "gatekeeper" (Sidransky 
1996; Trott and Roseman 2000). After loss of the gatekeeper function, clonal 
expansion of tissue-specific sten1 cells is allowed (Sidransky 1996). 
Radiation mutagenesis may principally proceed via DNA deletions through 
misrepair and misrecombination at DNA double-strand breaks (ICRP 1999; Trott 
and Roseman 2000). In our modeling of radiation-induced neoplastic transforma- 
tion, mutations are assumed to arise from misrepair of DNA damage, and nonlethal 
mutations are assumed responsible for the initial persistent genomic instability. 
Here, we have not distinguished between misrecombination of DNA double strand 
breaks, misrepair, or incomplete repair. Presently, we only distinguisl~ behvee~~ 
lethal and nonlethal mutations. 
Genomic Instability and Mutations 
The concept of genomic instability was introduced by W. F. Morgan and col- 
leagues (1996) and is now widely accepted. Genomic instability can propagate over 
successive cell generations (Morgan et al. 1996; Wright 1998). We consider all 
mutations to represent genomic instability. Problematic nonlethal mutations among 
dividing cells we consider to possess persistent problematic instability (PPI) transfer- 
able to progeny. Most radiation-induced mutations directly involve the loss of large 
parts of the tested gene, leading to loss of heterozygosity (Trott and Rosenlan 2000). 
However, most radiation-induced mutations associated with genomic instability are 
point mutations and small deletions (Little 1999). In modeling radiation-induced 
genomic instability, we do not assume PPI to be associated with a specific type of 
mutation. We only distinguish between lethal and nonlethal mutations, and we 
assume that neoplastic transformation arises as a stochastic process among cells 
(including progeny) with PPI. 
Some useful findings related to genomic instability have been reported in a study 
of 20 liver tumors, which were diagnosed in a cohort of people treated with 
Thorotrast (Iwamoto et al. 1999). It was found that 95% of the cases showed p53 
point mutations. Iwamoto et al. (1999) concluded that the relevant genetic alter- 
ations leading to liver cancer result from an induced genetic instability (indirect 
effect), rather than from radiation exposure directly. In our modeling of neoplastic 
transformation, we have characterized PPI as an indirect effect (arising via misrepair) 
of irradiation (or chemical exposure) that can be passed to cell progeny. We have 
also introduced a new class of genomic instability (transient; Scott 1997), which is 
now modeled as a direct effect (hit hypersensitive cells) and indirect effect (includ- 
ing deleterious bystander effects) of irradiation. 
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Apoptosis: Protector of the Cell Community from Stochastic Effects 
In contrast to the necrotic mode of cell death, apoptosis protects from problem- 
atic cells in the body via their elimination without causing inflammation (Mendonca 
et al. 1999). Strasser el al. (2000) summarized key points associated with apoptosis 
signaling as follows: 
Apoptosis, a physiological process for killing cells, is critical for the normal 
development and function of multicellular organisms. Abnormalities in cell 
death control can contribute to a variety of diseases, including cancer, autoim- 
munity, and dege~ierative disorders. Signaling for apoptosis occurs through 
multiple independent pathways that are initiated either from triggering events 
within the cell or from outside the cell, for instance, by ligatio~i of death 
receptors. 
New research results indicated that problematic cells in the body may be detected 
via molecular biological mechanisms and selectively eliminated via apoptosis to 
protect the cell community (Yang et al. 2000). A key assumption of the NEOTRANS, 
model to be introduced is that existing problematic cells (e.g., problematic mutants, 
neoplastically transformed cells) in the cell community can be signaled to undergo 
apoptosis and selectively eliminated via lowdose-induced protective bystander mecha- 
nisms. These mechanisms of reduction in cell community vulnerability status we 
presume to explain, at least in part, reported lowdose hypersensitivity to cell killing 
among cancer cell lines Uoiner et al. 1999) as well as virally transfected cells 
(Seymour and Mothersill 2000). 
Thus, the NEOTRANS, model to be presented includes both deleterious and 
protective bystander effects. 
Possible Mechanisms for Recognizing and Selectively Eliminating Problematic 
Cells 
As already indicated, we have hypothesized the existence of a protective apoptotic 
bystander effect for neoplastic transformation. Such an effect is necessary to ad- 
equately explain existing data whereby risks for neoplastic transformation (Azzam 
et al. 1996; Redpath d al. 2001) and lung cancer (Rossi and Zaider 1997) decrease 
rather than increase at very low doses. 
A crucial missing link related to our modeling is identification of mechanisms 
whereby problematic cells already present in a population can be recognized and 
signaled to undergo apoptosis, while nearby normal cells are essentially unaffected. 
Some progress is being made by researchers to identify and characterize such a 
protective process for the cell community. 
Cucinotta et al. (2002) point out that ionizing radiation produces DNA damage 
that causes protein fluctuations through binding damage recognition proteins to 
DNA breaks and subsequent downstream events. The type of fluctuations may 
depend on the type of DNA break such as simple or complex singlestrand breaks 
and double-strand breaks or base damage (Cunniffe and O'Neil 1999). 
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Barcellos-Hoff and Brooks (2001) point out that bystander effects after low doses 
of radiation are extracellular signaling pathways that modulate both cellular repair 
and death programs. The authors also indicate that transforming growth factor P 
(TGFBl) is known to be an extracellular sensor of damage. They further indicate 
that extracellular signaling relevant to carcinogenesis in normal tissue can eliminate 
abnormal cells or suppress neoplastic behavior. 
Dr. C.-R. Yang and colleagues (2000) at Case Western University have reported 
clusterin [CLU, a.k.a. TRPM-2, SGP-2, or radiation-induced protein-8 (XIPS)] to be 
implicated in apoptosis. In a recent study (Yang et al. 2000), they reisolated CLU/ 
XIP8 by yeast two-hybrid analyses, using as bait the DNA double-strand break repair 
protein Ku70. They showed that lowdose, radiation-induced nuclear CLU/XIP8 
protein coimmunoprecipitated and colocalized in vivo with Ku70/Ku80, a known 
DNA damage sensor and key double-strand break repair protein, in human MCF- 
7:WS8 breast cancer cells. Their key finding was that enhanced expression and 
accumulation of nuclear CLU/XIP&Ku70/Ku80 complexes appear to be an impor- 
tant cell death signal after irradiation. Further, their data suggest that CLU/XIP8 
may play an important role in monitoring cells with genomic instability and/or 
infidelity, created by translesion DNA synthesis, by facilitating removal of genetically 
unstable cells as well as severely damaged cells. Yang et al. (2000) strongly suggest 
that the CLU/XIP8 protein is a general cell death signal, monitoring overall cell 
health. 
Yang et al. point out that the recent findings that Ku70, but not Ku80, knockout 
mice are cancer prone appear consistent with the notion that formation of nuclear 
CLU/XIP8 with Ku70 may play an important role in eliminating carcinogenic 
initiated (problematic) cells. 
It is now known from in vitro studies of viral-induced neoplastic transforination 
(Bauer 1996) that: 
Increasing plating density reduces transformation frequency. 
Transformed cells are selectively killed via apoptosis. 
Cytokines and reactive oxygen produced by nontransformed neighboring cells 
trigger apoptosis. 
TGFBl enables nontransformed cells to trigger apoptosis among transformed 
cells. 
Given the above information, we consider our key modeling assumption of the 
existence of an inducible protective bystander apoptosis effect whereby problematic 
cells are recognized (after signaling from other cells) and selectively eliminated 
from the cell community to be highly plausible. 
Another assumption we make is that neoplastic transformation is a necessary 
early step for cancer induction (a widely held view). Thus, demonstrating lowdose- 
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induced protection from neoplastic transformation in uitro is consistent with the 
possibility of low-dose-induced protection from cancer in uiuo. 
Cellular Differentiation 
The current view is that some problematic cells may undergo differentiation 
(group resilience), and this also protects the cell community from propagating 
stochastic adverse effects. Presently, the NEOTRANS, model does not include this 
feature. We consider differentiation to be more important in uiuo than in uitro. Our 
modeling applications presented in this paper relate to in uitro studies. 
Deleterious Bystander Effects 
Deleterious bystander effects (Ballarini et al. 2002) whereby unirradiated cells are 
damaged have been examined in two general types of cellular systems. In the first, 
monolayer cultures have been exposed to very low fluences of alpha particles either 
from an external source (Nagasawa and Little 1992; Azzam et al. 1998; Little et al. 
2002) or focused microbeam (Hei et al. 1997; Prise et al. 1998). The second tech- 
nique involves harvesting medium from irradiated cells and incubating it with 
nonirradiated cells (Mothersill and Seymour 1997; Lyng et al. 2000). Both tech- 
niques have demonstrated that cells not being irradiated can still be damaged. 
Further, the bystander effect does not arise from simply irradiating media. Cell 
damage and intercellular signaling are essential. 
We also allow for the possibility of deleterious bystander effects via model param- 
eters that account for both direct and indirect deleterious radiation effects. 
THE NEOTRANS, MODEL AND ITS PREDECESSOR NEOTRANS, 
Our modeling research focuses on characterizing excess stochastic effects (mu- 
tations, neoplastic transformations) after very low doses of radiation by using mecha- 
nisms-based models. While many in uitro experimental studies have been conducted 
on radiation-induced neoplastic transformation, only limited experimental data are 
available for doses < 100 ~nGy (Azzam et al. 1994, 1996; Redpath and Antoniono 
1998; Redpath et al. 2001). 
In previous work, we introduced a class of models (that included NEOTRANS1) 
for characterizing neoplastic transformation of cells that relates the probability of 
neoplastic transformation to the state of genomic instability (Scott 1997; Schollnberger 
et al. 2001a; Scott et al. 2001). With NEOTRANS,, the target cell population was 
modeled as heterogeneous with both hypersensitive- and resistant-cell subpopula- 
tions (considered the simplest case of heterogeneity). NEOTRANS, has now been 
refined, leading to a model called NEOTRANS, (Figures 1 and 2) that includes 
apoptotic and necrotic death pathways. In this paper, NEOTRANS, is applied to in 
uitro data for low-radiation-dose-induced neoplastic transformation. We have fo- 
cused only on data with several dose groups I 100 mGy. 
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Genomic Instability States Used in NEOTRANS, 
Our use of terminology related to genomic instability is the same as used in 
earlier publications (Scott 1997; Schollnberger et al. 2001a). The expression "ge- 
oomic instability state" refers to any spontaneous or toxicant-induced instability in 
the genome, including any initial transient instability, as well as any persistent 
instability that can be passed to cell progeny. In addition to a stable (ST) genome, 
the NEOTRANS, model (as well as NEOTRANS,) involves four types of genomic 
instability (Figures 1 and 2) : (1) Normal-minor instability (NMI) , associated with 
normal cell function and normal genome status; (2) Transient-minor instability (TMI) , 
associated with toxicant-induced genomic damage that is fully repairable (without 
any significant errors); (3) i%nsient+roblematic instability (TPI), associated with 
genomic damage that may sometimes be fully repaired but can be misrepaired; and 
(4) PPI, which arises from misrepair that yields nonlethal mutations. Thus, PPI can 
be passed to progeny, increasing their potential for stochastic effects such as neo- 
plastic transformation. We use the term misrepair in a broad sense as already 
indicated. We consider TPI and PPI to be vulnerability states (for additional delete- 
rious stochastic effects). 
Other Model Features 
With the NEOTRANS, model, a very small fraction, To << 1, of the cell population 
is presumed to have already undergone neoplastic transformation over their life 
history. The discussion that immediately follows relates to the remaining vast major- 
ity ( I  - To = 1) of the cells. With both NEOTRANS, (Figures 1 and 2) and 
NEOTRANS,, only cells in the high vulnerability state PPI (viable mutants) can 
produce neoplastically transformed progeny. Only genomically ST cells, those with 
NMI, and those with PPI progress through the cell cycle and divide. Other cells are 
assumed arrested at cell cycle checkpoints (resilience facilitation) where genomic 
damage is repaired or misrepaired. Irradiation times were assumed quite short 
relative to cell cycle transit times, so that no equations were used to account for 
progression through the cell cycle during irradiation. Neoplastic transformations 
are assumed to occur as a stochastic process, and the transformed cells may have an 
altered cell cycle transit time distribution. 
With NEOTRANS,, target genes are specified (Figures 1 and 2) and include 
tumor suppressor genes, oncogenes, repair genes, apoptosis genes, and cellcycle 
regulator genes. Unlike NEOTRANS,, with NEOTRANS, cell killing is explicitly 
addressed and not treated as independent of neoplastic transformation. Two modes 
of cell death are considered: apoptosis (assumed to predominate at very low doses) 
and necrotic death (assumed important only at moderate and high doses). Again, 
nonlethal mutations are assumed to arise via misrepair. Lethal mutations are as- 
signed to the apoptosis pathway (including delayed lethal mutations). The analytical 
solutions in the present paper apply only to very low-radiation doses where necrotic 
death can be assumed negligible. 
Nonlinearity in Biology, Toxicology, and Medicine. Vol. 1, No. 1, 2003 101 
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Model parameters a, ,  a,, and a,, common to both NEOTRANS, and NEOTRANS,, 
reflect genomic sensitivity to initial and higher levels of damage production and 
should be multiplied by the dose rate c. The parameters p, and p, are also common 
to both models and govern the commitment rate of damaged cells to an error-free 
repair pathway. In addition, the parameters 11, and q2 are common to both models 
and govern the commitment rate of damaged cells to a misrepair pathway that leads 
to nonlethal mutant cells (PPI cells). 
In light of new evidence that protracted exposure to low-LET radiation can lead 
to large dose thresholds for cancer induction, we allow q1 and 11, to be step functions 
of dose rate. Below a critical dose-rate value c* (presently undetermined), the 
parameters take on a value of zero. This dose-rate threshold is presumed to depend 
on the type of radiation and type of cancer. For dose rates above c*, the parameters 
then take on fixed values > zero. The parameters @, and @, appear only in NEOTRANS, 
and govern the rate of commitment of damaged cells (including lethal mutations) 
to the apoptotic pathway. The parameters K, and K, (which are important only for 
moderate and high doses) appear only in NEOTRANS, and when multiplied by 
dose rate, govern the rate at which already damaged cells enter the necrotic death 
pathway. Typical units for a, and K, are mGyl. Typical units for h, qi, and @i are min-l. 
Parameters a, ,  a,, and a, should be viewed as being comprised of two parts: (1) 
one part relates to direct damage to DNA, (2) the other part relates to indirect 
damage to DNA and includes deleterious bystander effects. 
For very low-radiation doses, only hypersensitive cells are assumed to be induced 
to transform (new transformations) and cells are modeled as being killed only via 
the apoptotic pathway. Thus, only Figure 1 applies for very low doses and to the 
hypersensitive subfraction, f,, of cells at risk. 
Further, with our current version of the NEOTRANS, model, a fraction To 
(stochastic quantity) of cells at risk is assumed to have already undergone sponta- 
neous neoplastic transformation, based on genomic alterations over their life his- 
tory, but prior to dosing with radiation (or chemical). Because the life history of cells 
spans a long time compared to the short time period over which cells are irradiated 
during in uitro studies, this is considered a highly plausible assumption when apply- 
ing NEOTRANS, to data from in uitro irradiation studies. For in uiuo exposure, 
additional protective mechanisms could be important (Stecca and Gerber 1998; 
Barcellos-Hoff and Brooks 2001 ). 
Model Solutions for Very Low Doses 
Evidence is now strong that death via apoptosis at low radiation doses can occur 
via a bystander mechanism (Mothersill and Seymour 1998a, b; Lyng et al. 2000; 
Belyakov et at. 2001a, b, 2002a, b; Prise et al. 2002). We consider the highly plausible 
possibility that a fraction fo of the To cells already neoplastically transformed is killed 
via a bystander effect for apoptosis (a key modeling assumption). In such cases, the 
dose response at very low-radiation doses could decrease rather than increase. 
Indeed, this type of dose response has now been demonstrated experimentally with 
102 Nonlinearity in Biology, Toxicology, and Medicine. Vol. 1, No. 1, 2003 
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6OCogamma irradiation of C3H 10T1/2 cells (Azzam et al. 1996) and with 13'Cs- 
gamma irradiation of HeLa x skin fibroblast human hybrid cells (Redpath and 
Antoniono 1998; Redpath et al. 2001). 
The analytical solutions that follow apply to very small dose increments. As 
indicated, a small fraction To of cells in the population is modeled as already having 
the problem of interest (e.g.,  neoplastic transformation in this case, but a similar 
equation would apply to ilonlethal problematic mutations). At such doses, newly 
induced neoplastic transformations are modeled as arising from a small (in num- 
ber), hypersensitive subfraction of remaining (1 -To) cells at risk. This hypersensi- 
tive subfraction is given by f ,( l  - To) = f,. From Figure 1 (which shows only 
hypersensitive cells), it can be seen that a very small dose increment AD (where AD 
= c At, for a small time increment At) to the fraction f,(l -To) of hypersensitive cells 
will lead to an expected fraction f l ( l  - To)alAD of cells in the state TPI (assuming 
all hypersensitive cells are initially in the state NMI); for this fraction entering the 
transient state TPI, the conditional probability of subsequently undergoing misrepair 
(leading to PPI) is just q,/(p, + 77, t @,). 
The dose-response function for radiation-induced, neoplastic transformations 
per surviving cell, TFSC(AD), at very low doses AD is thus given by the following: 
TFSC(AD) = To , for AD = 0, 
TFSC(AD) = (1 - fo)To t [ ( l  - To)flalqlR/ (pl t q1 t $,)I AD, for AD > 0. (1) 
For AD > 0, Equation 1 has a fixed slope of (1 - To)flalqlR/(pl t 71, t $,). The 
parameter R is the proportion of the newly induced parental PPI cells that produce 
~~rol'laqtically transformed progeny. The parameter R, therefore, depends on fol- 
low-111) t i l ~ ~ c .  I t  is also likely influenced by the signaling characteristic of the cellular 
c - o ~ ~ ~ ~ ~ ~ r ~ n i t y  (Barcellos-Hoff and Brooks 2001). Equation 1 leads to the LNT model 
only ~vhen fo = 0 (i.e., when the protective apoptosis effect is absent) and q 1  > 0 
(misrepair occurs). 
Equation 1 is based on the assumption that intercellular signaling that leads to 
the protective bystander apoptosis effect occurs without a radiation dose threshold. 
Data to be presented later (Azzam et al. 1996; Redpath et al. 2001) support this 
hypothesis for ionizing radiation. However, this may not be the case for genotoxic 
chemicals (Walker et al. 2002). 
With Equation 1, the dose-response relationship is discontinuous at zero dose 
[steps down from To to (1 - fo)T,,]. The dose-response associated with Equation 1 is 
linear but with a zerodose intercept of (1 - fo)To rather than To when fitted to low- 
dose data with the zero-dose group excluded (see hypothetical dose-response curve 
in Figure 3). As indicated in Figure 3, To is stochastic. 
The dose-response curve for TFSC will exceed To (a random variable) only for AD 
in excess of a stochastic threshold (Stol'hresh) dose DTh (Figure 3) given by: 
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Figure 3. Hypothetical dose-response curve related to NEOTRANS, model. The param- 
eter To and the StoThl-esh, D,,, have distributions F(To) and G(D,,,), respectively. 
Here, we assumed that cell survival is very near 100% at the very low doses consid- 
ered and that TJ,, f,, a,,  f,, and R are all > 0. This is consistent with observations of 
Azzam et al. (1996). A StoThresh (as apposed to a deterministic threshold) is consid- 
ered to occur because T, as well as all other model parameters are treated as 
stochastic. 
Since T, is on the order of lo4 to 10" for most in vitro studies of neoplastic 
transformation, selectively killing all T, cells (i.e., f, = 1) would still lead to a cell 
survival fraction > 0.999. Unfortunately, currently available data at low doses for 
which equations apply are inadequate to derive distributions for individual model 
parameters p,, TJ,, Q,, f,, a,,  f,, and R. However, more general forms of Equations 1 
and 2 are derived and used in obtaining estimates off,, T,, and D.,. Since demon- 
strating that D,., > 0 has important implications for radiation protection and radia- 
tion risk assessment, these more general solutions are quite useful. 
Equation 1 can be rewritten in the more general form: 
TFSC (AD) = ( 1 - f,) T ,  + ( 1 - To) k,AD, (3) 
where 
k~ = flalTJlQ/(~l + v1 + $ 1 ) .  
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Equation 3 can be considered a generalized, three-parameter (stochastic param- 
eters f,, T,,, and kT) form of the NEOTRANS, model for application to very low- 
radiation doses. A corresponding equation may also apply to highly genotoxic 
chemicals, with AD then representing a very small dose of the agent of interest. For 
a constant exposure time (for a chemical), AD could be replaced by the concentra- 
tion with the parameter kT redefined to include the exposure time in the numera- 
tor. 
Equation 2 can also be rewritten in the more general form: 
Figure 3 shows a hypothetical mean dose-response curve based on Equations 3 and 
4. In the figure, hypothetical distributions F(T,) (shown vertically) and G(D,,) 
(shown horizontally) are presented for T, and DTh, respectively. 
For very low doses and in the framework of the NEOTRANS, model, it is possible 
that the protective bystander effect may predominate (f, >> kTAD) when the spon- 
taneous frequency To of transformation is relatively high and when f, > 0 and AD is 
very small (e.g., less than about 100 mGy low-LET radiation). Implied here is a 
relative small value for the slope parameter kT in combination with a small dose. In 
such cases, the data for radiation-associated neoplastic transformation (and for 
specific problematic nonlethal mutations) should be adequately represented by the 
relationships: 
TFSC(AD) = T,, for AD = 0 
= (1 - f,)T,, for AD > 0. (5) 
Further, TFSC (AD) should be uncorrelated with dose over the dose range for which 
the above applies. This requirement only applies to doses in excess of background. 
We later apply Equation 5 to two data sets for gamma-ray-induced neoplastic cell 
transformation for doses up to about 100 mGy. 
We describe later how distributions for T, (stochastic), DTh (stochastic), and the 
slope parameter kT have been obtained for induced neoplastic transformation. 
FITTING THE NEOTRANS, MODEL TO DATA 
Data Used to Estimate Model Parameters 
We fitted the protective bystander effects version of the model to available data 
for radiation-induced ileoplastic transformation (two data sets) and lowdose apoptosis 
(one data set): 
Data Set 1 - Gamma-ray-induced neoplastic transformation data of Redpath et 
al. (2001) (delayed plating) : 
HeLa x skin fibroblast human hybrid cells 
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13'Cs gamma rays 
* Dose rate: 3.3 mGy/min for dose < 100 mGy; 41.3 mGy/min otherwise 
Doses: 0, 1, 5, 10, 50, 100, 300, and 500 mGy 
Data Set 2 - Gamma-ray-induced neoplastic transformation data of Azzam et al. 
(1996) (delayed plating) : 
C3H 10T1/2 mouse embryo fibroblast clone 8 cells 
"Co gamma rays 
Dose rate: 2.4 mGy/min 
Doses: 0, 1, 10, and 100 mGy 
Data Set 3 - Gamma-ray-induced cell killing (via apoptosis) data of Seymour and 
Mothersill (2000) : 
Huinan keratinocytes (immortalizedviaviral transfection but not transformed) 
60Co gamma rays 
Dose rate: 750 mGy/min 
Doses: 0, 10, 30, 50, and 100 mGy 
Estimating Model Parameters 
For the narrow dose range (0 to 100 mGy), all data (for AD > 0) for transforma- 
tion and cell survival were uncorrelated with dose. This is in line with characteristics 
of the NEOTRANS, model that predicts that the largest effect at very low doses is 
the protective bystander apoptosis effect, which is modeled as being independent of 
dose. 
For data in the dose interval 0 to 100 mGy (excluding the zero dose group), the 
parameter f,, was evaluated for both the data of Redpath et al. (2001) and Azzam et 
al. (1996) as follows based on Equation 5. For 0 < AD I 100 mGy, fo for transforma- 
tion was calculated as a function of the mean observed transformation frequency, 
TFSC, and reported mean for To using the relationship 
Equation 6 was used for each dose in the dose range indicated leading to different 
estimates off,, and corresponding values (1-fo)To. Mean values for (1-fo)To and the 
associated standard deviation were obtained. Dose-response relationships (horizon- 
tal line) were based on these means and the associated 95% confidence intervals 
assuming a normal distribution. 
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Bayesian methods (Siva 1998) were used only for the neoplastic transformation 
data of Redpath et al. (2001) and only when doses over the wider range of 0 to 500 
nlGy were evaluated. For this dose range, Equations 5 and 6 do not apply. Equation 
3 applies and was therefore used. WinBUGS software (Spiegelhalter et al. 1999) was 
used to carry out the Bayesian inference via use of Markov Chain Monte Carlo 
(MCMC) analyses. Transformants were modeled as having Poisson distributions. 
For the Bayesian analysis, the prior distribution for k, was uniform over the interval 
(4 x 10-"7.5 x for f,,, a uniform prior distribution over the interval 0 to 1 was 
used; for To, a normal prior distribution was used with a mean of 2.24 x 10-bnd 
standard deviation of 2.8 x lo4 [same values as reported by Redpath et al. (2001)l. 
Five thousand MCMC iterations were first run. Auto correlations were then exam- 
ined to judge how many additional iterations were needed for convergence. Fewer 
than 30,000 iterations (total) were found needed to ensure convergence. Iterations 
were then increased so that the total was 60,000. These iterations were more than 
were needed, but they essentially guaranteed convergence of the Markov chains. 
The first 40,000 iterations were then discarded as burn-in. Analysis of posterior 
distributions was then based on the final 20,000 MCMC realizations. 
MODELING RESULTS 
Figure 4 shows results obtained for our analysis of the Azzam et a1.k (1996) data 
for gamma-ray-induced neoplastic transformation of C3H 10T1/2 cells in vitro. Only 
data in the very low dose range (0 to 100 mGy), where Equation 5 applies, were used. 
For this dose range (with the zero dose group excluded), there was no significant 
correlation between transformation frequency and dose (R2 = 0.18, p > 0.5). 
The corresponding results for application of the NEOTRANS, model to the 
Redpath ~t al. (2001) data for gamma-ray-induced neoplastic transformation of 
HeLa x skin fibroblast cells are presented in Figure 5. Solid points in these figures 
represent the experimental data, and snlooth and dashed curves represent model- 
associated results with means (central curve) and 95% confidence regions. For these 
data and for doses above zero, there was no significant correlation of transformation 
frequency with dose (R2 = 0.4, p = 0.2). 
In both Figures 4 and 5 the risk of neoplastic transformation clearly drops 
immediately below the spontaneous frequency to a fixed value independent of 
radiation dose, as predicted by the NEOTRANS, model (Equation 5). 
The mean and standard deviations for fo were 0.32 + 0.04 and 0.71 + 0.04 for the 
data of Redpath et aL (2001) and Azzam et al. (1996), respectively. The parameter 
fo mean was therefore 2.2 times larger for the C3H 10T1/2 cells than for the HeLa 
x skin fibroblast human hybrid cells. Similarly, the spontaneous frequency mean was 
about 76 times larger for the C3H 10T1/2 cells than for the HeLa x skin fibroblast 
cells. These results suggest that fo may be correlated with genetic sensitivity, being 
larger (more protective) for the more sensitive target cells. However, what implica- 
tion this has for sensitive individuals is unclear. 
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Figure 4. Application of the NEOTRANS, model to the Azzam et aL (1996) data (solid 
points) for gamma-ray-induced (in Yitro) neoplastic transformation of C3H 
10T1/2 cells for a dose range of 0 to 100 mGy. Model-associated means (central 
cune) ,  5% (percentile; lower cune) ,  and 95% (upper cune)  values are pre- 
sented based on an assumed normal distribution. 
Figure 5. Application of the NEOTRANS, model to the Redpath et aL (2001) data (solid 
points) for gamma ray-induced (in vitro) neoplastic transformation of HeLa x 
skin fibroblast human hybrid cells for the dose range 0 to 100 mGy. Model- 
associated means (central cline), 5% (percentile; lower curve), and 95% (upper 
cune)  values are presented based on an assumed normal distribution. 
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Figure 6 shows results of applying the NEOTRANS, model to a wider range of 
doses (0 to 500 mGy) based on the Redpath et al. (2001) data for gamma-ray- 
induced neoplastic transformation of HeLa x skin fibroblast human hybrid cells. 
Equation 3 was used in this analysis in conjunction with Bayesian methods. 
Transformants were modeled as having dosedependent Poisson distributions with 
the expected frequency given by Equation 3. Solid points in Figure 6 represent 
experimental data. Upper and lower lines drawn represent the upper and lower 
95% credibility bands (from Bayesian posterior distribution), and the central line 
represents the posterior mean. Model parameter estimates are presented in Table 
1 along with standard deviations, and 5% (percentile), 50%, and 95% values. 
The central line in Figure 6 has been used to demonstrate a protective effect of 
low-dose radiation against neoplastic transformation. Figure 7 shows the benefit 
(expected number of spontaneous transformants eliminated) to harm (expected 
number of newly induced transformants) ratio. A benefit/harm ratio >> 1 demon- 
strates potential for possibly eliminating early stage cancer cells from the body via 
lowdose irradiation (e.g., from radon in the home, living at a high altitude where 
cosmic ray doses are higher, etc.). Similar potential protection likely also exists for 
other inducers of apoptosis signaling (e.g., apoptosis-inducing chemicals in food 
such as isothiocyanates pang et al. 20021). Note that the benefit/harm ratio in- 
creases steeply as the dose decreases below about 50 mGy. The lowest dose featured 
on the curve is 10 mGy. For this dose, the benefit/harm ratio exceeds 600,000. This 
means that on average, for each newly induced transformant, more than 600,000 
assumed already present spontaneous transformants are eliminated via the pre- 
sumed protective bystander apoptosis effect. This is a pronounced protective effect 
since relatively little harm to a human would be expected to be associated with a 10 
mGy radiation dose, especially if protracted. Further, the benefit/harm ratio may 
increase as the period over which the dose is delivered increases because extending 
Table 1. NEOTRANS, model parameter and threshold estimates for data of 
Redpath et al. (2001) for gamma-ray-induced transformation of HeLa x 
skin fibroblast human hybrid cells. 
Parameter or Standard 
function Mean deviation 5' percentile 50' percentile 95' percentile 
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Figure 6. Application of the NEOTRANS, model to the Redpath et al. (2001) data (solid 
points) for gamma ray-induced (in v i h )  neoplastic transformation of HeLa x 
skin fibroblast human hybrid cells for the dose range 0 to 500 mGy. The central 
straight line is based on Bayesian posterior distribution mean for TFSC. Lower 
(5%; percentile) and upper (95%) values for the posterior distributions are also 
shown. The horizontal dash line is the posterior mean for T,. 
exposure also would be expected to prolong the period over which the protective 
bystander effect was operating. 
Similar protection has also been demonstrated in cancer chemoprevention 
studies where apoptosis-inducing isothiocyanates in the diet have prevented 
the occurrence of benzo(a)pyrene-induced lung tumors in mice (Yang et al. 
2002). 
Radiation may also induce the elimination of virally transfected cells via the 
protective bystander apoptosis effect. Figure 8 shows results obtained in model- 
ing the cell survival data of Seymour and Mothersill (2000) for gamma ray- 
induced apoptosis in human papillomavirus type 16 transfected (Pirisi et al. 
1988) human keratinocytes. The cell killing for the dose range 0 to 100 mGy was 
modeled as arising from a protective bystander effect that was independent of 
dose for AD > 0. As seen in Figure 8, the data are in excellent agreement with 
the modeling assumptions. For the indicated data and for doses > 0, there was 
no correlation between survival and dose (K2 = 0.04, p > 0.5). The parameter f,, 
(for removal of problematic cells) was found to have a mean and standard 
deviation of 0.37 + 0.08 (i.e., 37% of problematic virally transfected cells are 
expected to be removed via a protective bystander apoptosis effect). 
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Figure 7. Benefit (spontaneous transformants eliminated) to harm (newly induced 
transformants) ratio based on the central line in Figure 6 for the neoplastic 
transformation data of Redpath et al. (2001). 
DISCUSSION 
With the NEOTRANS, model, neoplastic transformation arises as a stochastic 
process but only for cells in the high vulnerability state PPI. The PPI (spontaneous 
or induced) is assumed to arise via nonlethal mutational events. These mutations 
are the type described by Mothersill and Seymour (1998b) as nonlethal but possibly 
cancer-facilitating mutations. 
Results in Figures 4 and 5 are consistent with predictions of the NEOTRANS, 
model that for very low doses of low-LET radiation, TFSC(AD) should be below the 
spontaneous frequency and independent of dose (e.6, in the range 0 to 100 mGy). 
Results in Figure 6 for gamma ray-induced neoplastic transformation of HeLa x skin 
fibroblast human hybrid cells have 5% (percentile), 5076, and 95% values for the 
Bayesian posterior distribution for the StoThresh of approxiinately 50, 150, and 250 
mGy, respectively. We can state that the data used are consistent with a StoThresh and 
that the Bayesian posterior distribution for the threshold assigns essentially a zero 
probability for the threshold being zero. A value of zero corresponds to the LNT 
model. The dose-response curve for excess transformations is clearly of the nonlin- 
ear, threshold type. 
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Figure 8. Observed and simulated survival of gamma-irradiated human papillomavirus 
hansfected keratinocytes based on the Seymour and Mothersill (2000) data 
(solidpoints). Analyses were performed for the dose range 0 to 100 mGy. Model- 
associated means (central curve), 5% (percentile; lower curve), and 95% (upper 
curve) values are presented based on an assumed normal distribution. 
A similar analysis was attempted for fission neutron (Hill et nl. 1984; Balcer- 
Kubiczek and Harrison 1991) and for alpha particle data of others (Bettega et nl. 
1992) for induced neoplastic transformation. However, a close examination of 
posterior distributions for the StoThresh revealed modes (highest values in the 
distribution function) very close to zero with the distributions having a tail to the 
right but not to the left of the modes. Such results indicate that a zerodose 
threshold for the high-LET radiation-induced neoplastic transformation could not 
be excluded based on the very limited data used. Central (mean) estimates of the 
thresholds were < 10 mGy, which would be very difficult to demoi~strate xperimen- 
tally. 
We now introduce the term group ( G) adaptation to describe any cell commuility 
adaptation initiated by a group of cells that protects the cell cornmuility (including 
the elimination of problematic cells as well as reducing cell vulnerability by cell 
differentiation). Gadaptation therefore also applies to lowdose radiation therapy 
for cancer (used in Europe but currently forbidden in the U.S.) assuming problem- 
atic cancer cells to be signaled via irradiated normal cells to undergo apoptosis. 
Where an individual cell adapts to an environmental stress by changing its 
resilience or vulnerability status, we called this individual (I) adaptation. Thus, 
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21-adaptation can be beneficial or problematic, depending on the endpoint consid- 
ered. An example of beneficial I-adaptation would be the induction of an error-free 
repair process, thereby increasing the cells' resilience to the induction of stochastic 
effects. An example of problematic I-adaptation would be a stress-related induction 
of an error-prone repair process producing viable mutations that facilitate the 
occurrence of neoplastic transformations. 
Another example of problematic I-adaptation is when an individual cell through 
adapting to a different environment has a net reduction in its capacity to undergo 
apoptosis. A reduced capacity to undergo apoptosis increases the risk for stochastic 
effects such as neoplastic transformation and cancer. Studies at our Institute suggest 
that background radiation can influence cells through problematic I-adaptation, 
Dr. Saxena and colleagues (2002) have conducted studies whereby cells irradiated 
after maintenance at background radiation levels were compared to corresponding 
cells irradiated after being maintained at lower than background (via special shield- 
ing). The cells maintained at lower than normal background had reduced compe- 
tence for undergoing apoptosis. These finding are in line with the view that back- 
ground radiation may serve as a natural nutrient. Moving from a region of moderate 
background radiation to a region of lower background may over time increase one's 
susceptibility to the induction of stochastic effects. 
Note that the view that problematic I-adaptation can lead to an increase in cancer 
risk is consistent with reported cancer risks from radon in homes (Cohen 1995). Dr. 
Cohen (1995) reported lung cancer mortality related to residential radon exposure 
in the U.S. After adjusting for smoking, lung cancer mortality was found to decrease 
with increasing mean residential radon levels. 
Some early modeling publications attempted to explain high-LET radiation 
inverse dose rate effect in vivo based on cell culture studies where cells were 
irradiated over several hours (Brenner and Hall 1990; Elkind 1994). These models 
were essentially based on the hypothesis that cells would be repeatedly hit at 
sensitive stages of the cell cycle during protracted irradiation. Such a hypothesis is 
inconsistent with the observation that damaged cells are arrested at cell-cycle check- 
points rather than progress through the cell cycle. Further, biological kinetics over 
a few hours cannot explain inverse dose rate effects from radiation doses delivered 
over months to years. We speculate that inverse dose rate effects, such as those seen 
by Dr. Cohen (1995) that involve dose delivery over months to years, are more likely 
related to problematic I-adaptation, where cells in lower radiation environments 
(relative to an optimum) lose ability to undergo apoptosis. Additional problematic 
I-adaptation may be associated with the known decrease in DNA repair efficiency 
with increasing age. 
With the current version of NEOTRANS,, a fraction f, of the spontaneous 
neoplastic transformants is eliminated via a radiation- (or chemical-) induced pro- 
tective bystander apoptosis effect. The parameter f, can be viewed as representing 
the number of present spontaneous neoplastic transformants (of the type of inter- 
est) eliminated via the protective bystander apoptosis effect divided by the total 
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number of spontaneous neoplastic transformants present. We give the parameter f, 
the special name protection factor (PROFAq. Thus, the PROFAC represents the 
removal efficiency via intercellular signaling mechanisms of existing problematic 
cells among the problematic cells present. The PROFAC is considered to relate to 
-adaptation but its magnitude may be influenced by I-adaptation. 
Using our NEOTRANS, model, which includes a protective bystander effect via 
apoptosis, we have found a rather large StoThresh for gamma-ray-induced neoplastic 
transformation of HeLa x skin fibroblast human hybrid cells. Others (Kondo 1999; 
Feinendegen et al. 2000; Tanooka 2000; Yamamoto and Seyama 2000; Feinendegen 
and Pollycove 2001) also put forth the notion that a threshold for radiation-induced 
excess stochastic effects could arise from such a protective mechanisms. 
In the current version of NEOTRANS,, the misrepair pathway is assumed to apply 
only for a dose rate in excess of a critical value c*. This has been changed in the 
model to account for others' observation that chronically administered (low-dose 
rate) low-LET irradiation appears to induce cancer (at certain sites in the body) only 
after very large radiation doses, if at all (Ootsuyama and Tanooka 199 1, 1993; Kossi 
and Zaider 1997; Yamamato et al. 1998; Kondo 1999; Yamanlato allti Seyama 2000; 
Tokarskaya et al. 2002). 
Harold Rossi and Marco Zaider (1997) critically reviewed the literature on 
radiogenic lung cancer and concluded that "at radiation doses generally of concern 
in radiation protection (< 2 Gy), protracted exposure to low-LET radiation (x- or 
-rays) does not appear to cause lung cancer. There is, in fact, indication of a 
reduction of the natural incidence." 
Hoe1 and Li (1998) have demonstrated that use of a threshold-type, dose-re- 
sponse model leads to better characterization of both the leukemia incidence and 
mortality data for atomic bomb survivors than use of the LNT model. In addition, 
Zoya Tokarskaya and colleagues (1995,1997) reported a threshold close to 1 Gy for 
lung cancer induction by alpha radiation, based on Mayak workers who inhaled 
plutonium-239. R. E. Rowland (1994) has reported a large threshold for bone 
cancer illduction by alpha radiation based on data for radium dial painters. 
The recent Hanford Thyroid Disease Study did not find evidence for any excess 
risk of thyroid cancer induction for persons who were exposed to radioactive iodine 
released from the Hanford facility (USDHHS 2002). For doses in the range of 0 to 
100 mGy, risk was not correlated with dose and was less than for the control group 
based on persons outside what was considered the irradiation zone. Further, for 
several health effects, the mean slope of the risk vs. dose relationship was negative. 
It is important to point out implications of our findings related to low-dose 
risk assessment for chronic exposure. Firstly, Gadaptation can lead to protec- 
tion of the cellular community from low-dose-induced stochastic effects. How- 
ever, there is a possibility that some risk gains and risk losses can occur. Persons 
who would have developed spontaneous cancers may be protected by low-dose 
exposure, while others exposed and who would not have developed spontaneous 
cancer may have added risk (likely very small if any) for cancer induction. 
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The net population effect could be a reduction in the number of cancer cases 
after low-dose exposure, but the subgroup that would not have developed spon- 
taneous cancers might have a higher cancer incidence. This poses some "food 
for thought" for the future discussion of protecting the public from low doses of 
genotoxic agents. 
The NEOTRANS, model has also been adapted for ethylene oxide (E0)-induced 
mutations in T cells of mice after inhalation exposure to a genotoxic chemical 
(Walker et al. 2002). The International Agency for Research on Cancer has classified 
EO (an immediate oxidative metabolite of ethylene, a normal body constituent) as 
a Group 1 human carcinogen based on suficient evidence in animals with strong 
evidence in humans of a relevant carcinogenic mechanisms, rather than on support 
from epidemiological studies of EOexposed workers (IARC 1994). For application 
to chemicals such as EO, the variable c then becomes the timedependent exposure 
concentration or dose rate (a.g., for a critical metabolite) to target tissue. The 
indicated adapted model, called NEOTRANS,-EO, includes a postulated threshold 
concentration for the induction of intercellular signaling that leads to the protective 
bystander apoptosis effect as well a second threshold for excess mutations (Walker 
et nl. 2002). 
We have explained the low-dose protective effects against radiation-induced 
neoplastic transformation as being due to a bystander apoptosis effect. Another 
possible explanation would be the induction of a highly efficient repair process that 
is not available at background levels of irradiation. However, we do not consider the 
notion of induced efficient repair adequate to explain a decrease in risk for neoplas- 
tic transformation. For one reason, the induced repair process may not be highly 
efficient (for protecting against problematic cells) as recently demonstrated 
(Oudalova et al. 2002). The cited researchers demonstrated that inoderate doses (> 
400 mGy) induce a system of SOS response leading to elevated survival and elevated 
yield of chromosomal aberrations among surviving cells (meristem cells of spring 
barley). Secondly, with induced efficient repair, plating efficiency for lowdose- 
irradiated cells should then be significantly higher than for controls, which appears 
not to be the case. 
It is important to mention the issue of genetic sensitivity. Some humans are 
highly sensitive to low-dose radiation-induced stochastic effects, due to inherited 
abnormalities in DNA repair. How the protective bystander apoptosis effect pre- 
sented here relates to such individuals has not been resolved. One could speculate 
that such individuals would have high frequency of spontaneous neoplastic trans- 
formations. If so, how these individuals will be affected by low-dose radiation or 
low-dose chemicals would be expected to depend on their ability to mount a 
protective response via apoptosis. Since both DNA repair and apoptosis are regu- 
lated through signaling pathways that involve p53, it is possible that persons with 
inherited deficiencies in DNA repair will also have deficiencies in apoptosis. If so, 
such individuals may not benefit from the protective bystander apoptosis effect 
discussed. 
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CONCLUSIONS 
Nonlinearity in the dose-response relationship for the risk of radiation- (or  
chemical-) induced problematic, nonlethal mutations and neoplastic transforma- 
tion could arise via several mechanisms: 
1. T h e  induction of a protective bystander apoptosis effect whereby existing 
problematic cells are selectively eliminated. 
2. Only error-free repair below a specific dose rate with misrepair occurring 
above that dose rate. 
3. An induction of an  error-prone repair process above a dose threshold whereby 
cells with significant genomic damage are more likely to survive. This would 
b e  expected to lead to an increase in mutations and neoplastic transforma- 
tions and  possibly for cancer cases (rather than a decrease). 
Both 1 and 2 above would b e  expected to lead to a threshold for excess (relative 
to the spontaneous level) problematic mutations, excess neoplastic transformation, 
and possibly for excess cancers. 
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